Drug Development

Articles

The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System 

Intravacc is partnering with Leiden University Medical Center for the development and evaluation of a new intranasal coronavirus vaccine candidate in a clinical Phase I/II study. 

Clinical Trial on Intranasal Coronavirus Vaccine Set to Start

With this investment into Yapan Bio, Piramal Pharma adds new technologies and capabilities in large molecules, including vaccines and gene therapies, to its global offering.

Piramal Pharma Invests Minority Stake in India-Based CDMO, Yapan Bio

Michael Moedler, PhD, is head of Training at Lonza Biologics Operations Visp.

Helene Pora, PhD, is vice-president of Technical Communication and Regulatory Strategy at Pall Corporation.

Workforce training is crucial for biopharmaceutical manufacturing.

Addressing the Training Gap for Single-Use Technologies

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Dosage form and patient needs drive excipient choice.

Taste and Appearance: Selecting the Right Excipients 

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.

Tackling the Big Issue of Solubility

Cheryl Barton is director of PharmaVision, 

DTx manufacturers are taking advantage of the new regulatory flexibility, afforded by the COVID-19 pandemic, to pilot new products and generate real-world evidence to support regulatory filing and reimbursement.

Regulating Digital Therapeutics

Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.

ISPE Publishes Guide for ATMP Facilities

Sanofi’s acquisition of Origimm Biotechnology will add to its pipeline of vaccine candidates for treating acne.

Sanofi to Acquire Origimm Biotechnology for Vaccine-based Acne Treatment

Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization. 


Formulation and Drug Delivery